ZA916290B - Substituted pyrimidine derivatives,a process for the preparation thereof and the use thereof as reagents - Google Patents

Substituted pyrimidine derivatives,a process for the preparation thereof and the use thereof as reagents

Info

Publication number
ZA916290B
ZA916290B ZA916290A ZA916290A ZA916290B ZA 916290 B ZA916290 B ZA 916290B ZA 916290 A ZA916290 A ZA 916290A ZA 916290 A ZA916290 A ZA 916290A ZA 916290 B ZA916290 B ZA 916290B
Authority
ZA
South Africa
Prior art keywords
reagents
preparation
pyrimidine derivatives
substituted pyrimidine
sorbitol
Prior art date
Application number
ZA916290A
Other languages
English (en)
Inventor
Karl Geisein
Geisein Karl
Roland Utz
Utz Roland
Hildegard Nimmesgern
Nimmesgern Hildegard
Hans-Jochen Lang
Lang Hans-Jochen
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA916290B publication Critical patent/ZA916290B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Luminescent Compositions (AREA)
ZA916290A 1990-08-10 1991-08-09 Substituted pyrimidine derivatives,a process for the preparation thereof and the use thereof as reagents ZA916290B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4025387A DE4025387A1 (de) 1990-08-10 1990-08-10 Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als reagenzien

Publications (1)

Publication Number Publication Date
ZA916290B true ZA916290B (en) 1992-04-29

Family

ID=6412013

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA916290A ZA916290B (en) 1990-08-10 1991-08-09 Substituted pyrimidine derivatives,a process for the preparation thereof and the use thereof as reagents

Country Status (16)

Country Link
US (1) US5215990A (xx)
EP (1) EP0470616B1 (xx)
JP (1) JP3094535B2 (xx)
KR (1) KR100191385B1 (xx)
AT (1) ATE149032T1 (xx)
AU (1) AU641797B2 (xx)
CA (1) CA2048842C (xx)
DE (2) DE4025387A1 (xx)
DK (1) DK0470616T3 (xx)
ES (1) ES2097774T3 (xx)
GR (1) GR3022976T3 (xx)
IE (1) IE912828A1 (xx)
IL (1) IL99134A (xx)
NZ (1) NZ239310A (xx)
PT (1) PT98634B (xx)
ZA (1) ZA916290B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR950703539A (ko) * 1992-09-28 1995-09-20 알렌 제이. 스피겔 당뇨병 합병증 치료용 치환된 피리미딘(substituted pyrimidines for control or diabetic complications)
DE69711965T2 (de) * 1996-02-29 2003-01-23 Pfizer Inc., New York Verwendung von Sorbitol-Dehydrogenase-Inhibitoren zum Reduzieren von Ischämie-assozierten Gewebeschäden
JPH09301868A (ja) * 1996-05-10 1997-11-25 Senju Pharmaceut Co Ltd 抗白内障剤
DE19710435A1 (de) * 1997-03-13 1998-09-17 Hoechst Ag Verwendung von Pyrimidinderivaten zur Prävention von Krebs allein oder in Kombination mit anderen therapeutischen Maßnahmen
EP1185275A1 (en) * 1999-04-01 2002-03-13 Pfizer Products Inc. Aminopyrimidines as sorbitol dehydrogenase inhibitors
DE60009777T2 (de) * 1999-04-01 2004-08-19 Pfizer Products Inc., Groton Verbindung für Behandlung und Vorsorge bei Diabetes
EP1247809A3 (en) 2001-03-30 2003-12-17 Pfizer Products Inc. Triazine compounds useful as sorbitol dehydrogenase inhibitors
WO2004000318A2 (en) * 2002-06-21 2003-12-31 Cellular Genomics, Inc. Certain amino-substituted monocycles as kinase modulators
AU2003245669A1 (en) * 2002-06-21 2004-01-06 Cellular Genomics, Inc. Certain aromatic monocycles as kinase modulators
WO2005110413A2 (en) 2004-05-19 2005-11-24 Solvay Pharmaceuticals Gmbh Medicaments containing n-sulfamoyl-n'-arylpiperazines for the prophylaxis or treatment of obesity and related conditions
US20050261292A1 (en) * 2004-05-19 2005-11-24 Solvay Pharmaceuticals Gmbh Pharmaceutical composition containing N-sulfamoyl-N'-arylpiperazines for the treatment or inhibition of obesity and related conditions
CN115124475B (zh) * 2022-07-11 2023-11-10 贵阳学院 一种嘧啶衍生物及其制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2362276A (en) * 1942-03-31 1944-11-07 American Cyanamid Co Beneficiation of acidic minerals
US2973362A (en) * 1959-07-24 1961-02-28 Schorsch Gerald Method of preparing monosubstituted piperazines
US3190883A (en) * 1962-10-05 1965-06-22 Geschickter Fund Med Res Aminoalkanol derivatives of piperazines
US3296261A (en) * 1965-03-09 1967-01-03 Bristol Myers Co 6-hydroxy-pyrimidine-5-acetamides
DK8600939A (xx) * 1985-03-05 1986-09-06
DE3905364A1 (de) * 1989-02-22 1990-08-23 Hoechst Ag Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als tool

Also Published As

Publication number Publication date
DK0470616T3 (da) 1997-08-25
IL99134A0 (en) 1992-07-15
EP0470616A3 (en) 1992-03-25
IE912828A1 (en) 1992-02-12
EP0470616A2 (de) 1992-02-12
AU8256191A (en) 1992-02-13
CA2048842C (en) 2002-04-09
KR920004381A (ko) 1992-03-27
EP0470616B1 (de) 1997-02-19
ES2097774T3 (es) 1997-04-16
IL99134A (en) 1995-08-31
US5215990A (en) 1993-06-01
JPH04230669A (ja) 1992-08-19
KR100191385B1 (ko) 1999-06-15
PT98634B (pt) 1999-01-29
DE59108549D1 (de) 1997-03-27
GR3022976T3 (en) 1997-06-30
NZ239310A (en) 1993-07-27
CA2048842A1 (en) 1992-02-11
DE4025387A1 (de) 1992-02-13
JP3094535B2 (ja) 2000-10-03
PT98634A (pt) 1993-09-30
AU641797B2 (en) 1993-09-30
ATE149032T1 (de) 1997-03-15

Similar Documents

Publication Publication Date Title
IL93465A0 (en) Substituted pyrimidine derivatives,process for their preparation and the use thereof as a tool
IL99134A0 (en) Substituted pyrimidine derivatives,a process for the preparation thereof and the use thereof as reagents
PL295030A1 (en) Method of obtaining substituted derivatives of 2-cyclohexan-1-yl amine
DE69620443D1 (de) Naphthyl substituierte benzimidazolderivate als antikoagulantien
FI925820A (fi) Bisbenso- eller bensopyrodcykloheptapiperiden-, piperidyliden och pieratzinfoereningar och -kompositioner
EP0176032A3 (en) Tetralin derivatives, their preparation and use
YU126291A (sh) Substituisani azoli, postopek za njihovo pripravo i njihova uporaba
DE3668621D1 (de) Verfahren zur herstellung von pteridinderivaten.
IL90309A0 (en) 6-phenyl-3-(piperazinylalkyl)-2,4(1h,3h)-pyrimidinedione derivatives,their preparation and their application in therapy
ES547856A0 (es) Procedimiento de preparar derivados de nucleosidos y purinas8-substituidos
ES2080336T3 (es) Derivados de metilpiperazinoazepina, su preparacion y su utilizacion.
DE59007185D1 (de) Substituierte 1.2.3.4-Oxatriazolium-5-olate, Verfahren zu ihrer Herstellung und ihre Verwendung.
CS315391A3 (en) Ergoline derivatives and process for preparing thereof
MX9307735A (es) Nuevas triazolopirimidonas, su obtencion y uso.
BG50775A1 (en) Derivatives of 2, 3- dimethyl- 1- phenyl- 4- (2- phenylmorpholinomethyl)- 5- pyrazolones and method for their preparation